SS
RANI icon

SBI Securities’s Rani Therapeutics RANI Stock Holding History

SBI Securities’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
15,509
+1,159
+8% +$1.03K ﹤0.01% 1754
2026
Q1 		$10.5K Buy
14,350
+562
+4% +$718 ﹤0.01% 1699
2025
Q4 		$18.6K Buy
13,788
+1,156
+9% +$1.74K ﹤0.01% 1474
2025
Q3 		$6.31K Buy
12,632
+3,012
+31% +$1.57K ﹤0.01% 1950
2025
Q2 		$4.94K Buy
9,620
+1,928
+25% +$1.57K ﹤0.01% 1987
2025
Q1 		$9.69K Buy
7,692
+593
+8% +$877 ﹤0.01% 1621
2024
Q4 		$9.73K Buy
+7,099
New +$14.9K ﹤0.01% 1659

Other funds holding RANI

KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
WDL
Well Done LLC Holland, Michigan $743M AUM 22.58% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

SBI Securities's RANI Position: Q2 2026 in Review

SBI Securities increased its Rani Therapeutics (RANI) stake by 8.1% in Q2 2026, buying an estimated $1.03K and bringing the position to 15,509 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

SBI Securities first reported a position in RANI in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.6K in Q4 2025. 13 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • SBI Securities held 15,509 shares of Rani Therapeutics worth $11.8K as of Q2 2026.
  • SBI Securities bought 1,159 Rani Therapeutics shares in Q2 2026, an estimated $1.03K.
  • Rani Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1754 holding.
  • SBI Securities first reported a position in Rani Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Rani Therapeutics position peaked at $18.6K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.